Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

"Hanmi"
Topics

Advertisement

Advertisement

"Hanmi"

Showing articles that match "Hanmi" in the headline

In the last 4 hours

Hanmi puts AI to work on 4,000 SOPs in quality assurance overhaul Korea Biomedical Review 08:28

Friday

Hanmi’s once-weekly hyperinsulinism drug advances in global phase 2 Korea Biomedical Review 06:27 Fri, 04 Sep

Thursday

Here's Why We Think Hanmi Pharm (KRX:128940) Is Well Worth Watching Simply Wall St 05:25 Thu, 03 Sep

Advertisement

Advertisement

In the last month

Hanmi Science taps Megazone to expand AI use across group Korea Biomedical Review 08:16 Tue, 01 Sep

Hanmi Pharm in spotlight as Korea's 1st obesity drug nears launch The Korea Times 07:15 Wed, 26 Aug

Genentech licenses Hanmi’s UCN2 obesity candidate in $2.3bn deal European Pharmaceutical Review 11:06 Tue, 25 Aug

Roche outlays $2.3bn for Hanmi’s non-GLP-1 obesity candidate Pharmaceutical Technology 23:40 Mon, 24 Aug

Hanmi that CV MoA: Roche lured to $2.3B metabolic pact BioWorld 21:41 Mon, 24 Aug

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug... pharmaphorum 15:37 Mon, 24 Aug

Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal Manufacturing Chemist 10:18 Mon, 24 Aug

Hanmi lands $2.3 billion obesity drug deal with Roche's Genentech Korea JoongAng Daily 09:37 Mon, 24 Aug

Hanmi Pharm signs 3.2 tln-won licensing deal with Roche's Genentech for obesity drug candidate Yonhap News Agency 09:02 Mon, 24 Aug

Hanmi Pharm shares surge 30% after $2.3 bil. Genentech obesity drug deal Korea Biomedical Review 07:58 Mon, 24 Aug

Hanmi Pharm signs $2.3 bil. licensing deal with Roche's Genentech for obesity drug candidate The Korea Times 07:22 Mon, 24 Aug

Hanmi signs record $2.3b obesity drug deal with Genentech The Korea Herald 06:31 Mon, 24 Aug

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy PR Newswire (Press Release) 05:45 Mon, 24 Aug

Hanmi highlights clopidogrel's long-term edge over aspirin after PCI Korea Biomedical Review 03:32 Mon, 24 Aug

Hanmi Pharmaceutical ahead of launching anti-obesity drug EPPE Asia Today 02:49 Thu, 20 Aug

Advertisement

Hanmi Financial (HAFC) Could Be a Great Choice Zacks 17:47 Wed, 19 Aug

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Australia Australia
World World
Sport Sport
Business Business
Entertainment
Science Science
Technology Technology
Lifestyle Lifestyle